Multi-omics and single-cell approaches reveal molecular subtypes and key cell interactions in hepatocellular carcinoma.

Journal: Frontiers in pharmacology
Published Date: May 22, 2025

Abstract

INTRODUCTION: Hepatocellular carcinoma is a highly aggressive and heterogeneous malignancy with limited understanding of its heterogeneity.

Authors

  • Xueqing Zou
    Department of Anesthesiology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
  • Yongmei Wang
    The Second Hospital of Jilin University, Changchun, 130000, Jilin, People's Republic of China.
  • Mingyuan Luan
    Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany.
  • Yizheng Zhang
    Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals